Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Bunse, Mario Dr. (1) Clauß, Julian (1) Daniel, Peter Prof. Dr. (1) Höpken, Uta Elisabeth PD Dr. (1) Ivics, Zoltan Dr. (1) Izsvak, Zsuzsanna Dr. (1) Kammertöns, Thomas Dr. (5) Kieback, Elisa Dr. (1) Kopp, Joachim Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (2) Na, Il-Kang Dr. (1) Rehm, Armin Dr. (1) Willimsky, Gerald Dr. (4) (-) Blankenstein, Thomas Prof. Dr. (20) (-) Nguyen, Tam Hoai Dr. (1) (-) Pezzutto, Antonio Prof. Dr. (2) (-) Uckert, Wolfgang Prof. Dr. (6) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (9) (-) 2004 (8) 2005 (10) 2006 (1) 2007 (6) 2008 (5) 2009 (2) 2010 (7) (-) 2011 (5) 2012 (6) 2013 (11) (-) 2014 (3) 2015 (3) 2016 (5) 2017 (6) (-) 2018 (6) 2019 (6) 2021 (4) 2022 (6) 2023 (4) 2024 (2) AG Müller/Dechend (ECRC) (1) Anchored Signalling (1) Cellular Neurosciences (2) Epigenetic Regulation and Chromatin Architecture (11) Experimental Ultrahigh-Field MR (1) From Cell States to Function (1) Hypertension-caused End-Organ Damage (1) Hypertension-Mediated End-Organ Damage (1) Immune Dysregulations in Oncology (1) Immune Regulation and Cancer (1) Intracellular Proteolysis (1) Magnetic Resonance (1) Microenvironmental Regulation in Autoimmunity and Cancer (1) Mobile DNA (1) Molecular Biology of Peptide Hormones (1) Molecular Cardiovascular Research (1) (-) Molecular Immunology and Gene Therapy (22) Out-patient Clinic for Neuroimmunology (1) Pancreatic Organoid Research and Disease Modeling (1) Proteome Dynamics (1) Psychoneuroimmunology (1) RNA Biology and Posttranscriptional Regulation (1) Structural Biology of Membrane-Associated Processes (1) Systems Biology of Gene Regulatory Elements (4) Translational Oncology of Solid Tumors (1) Translational Tumorimmunology (1) 22 Results: Active Filter: Blankenstein, Thomas Prof. Dr.Nguyen, Tam Hoai Dr.Pezzutto, Antonio Prof. Dr.Uckert, Wolfgang Prof. Dr.Molecular Immunology and Gene Therapy2004201120142018 Sort: Result score Newest to oldest Oldest to newest January 01, 2004 / J Immunol Long-term suppression of tumor growth by TNF requires a Stat1- and IFN regulatory factor 1-dependent IFN-γ pathway but not IL-12 or IL-18 T.H. Wu C.N. Pabin Z.H. Qin T. Blankenstein M. Philip J. Dignam K. Schreiber H. Schreiber January 23, 2004 The role of inflammation for tumour growth and tumour suppression T. Blankenstein January 01, 2004 / J Immunol Establishment of early lymphoid organ infrastructure in transplanted tumors mediated by local production of lymphotoxin alpha and in the combined absence of functional B and T cells H.J. Kim T. Kammertoens M. Janke O. Schmetzer Z. Qin C. Berek T. Blankenstein January 01, 2004 / Gene Ther Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1/TH2 polarization J. Westermann T. Nguyen-Hoai A. Mollweide G. Richter O. Schmetzer H.J. Kim T. Blankenstein B. Doerken A. Pezzutto August 01, 2004 / Immunity CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions L. Ohl M. Mohaupt N. Czeloth G. Hintzen Z. Kiafard J. Zwirner T. Blankenstein G. Henning R. Foerster January 01, 2004 / Nat Immunol A cancer immunosurveillance controversy Z.H. Qin T. Blankenstein January 01, 2004 / Int J Cancer CD4+ T cell-mediated HER-2/neu-specific tumor rejection in the absence of B cells J.A. Lindencrona S. Preiss T. Kammertoens T. Schueler M. Piechocki W.Z. Wei B. Seliger T. Blankenstein R. Kiessling July 01, 2004 / Eur J Immunol Dual T cell receptor T cells with two defined specificities mediate tumor suppression via both receptors M. Gladow W. Uckert T. Blankenstein December 01, 2014 / Canc Res Efficacy of CAR T-cell therapy in large tumors relies upon stromal targeting by IFNγ A. Textor J.J. Listopad L.L. Wührmann C. Perez A. Kruschinski M. Chmielewski H. Abken T. Blankenstein J. Charo July 28, 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein Pagination Current page 1 Page 2 Page 3 Next page Next › Last page Last »
January 01, 2004 / J Immunol Long-term suppression of tumor growth by TNF requires a Stat1- and IFN regulatory factor 1-dependent IFN-γ pathway but not IL-12 or IL-18 T.H. Wu C.N. Pabin Z.H. Qin T. Blankenstein M. Philip J. Dignam K. Schreiber H. Schreiber
January 01, 2004 / J Immunol Establishment of early lymphoid organ infrastructure in transplanted tumors mediated by local production of lymphotoxin alpha and in the combined absence of functional B and T cells H.J. Kim T. Kammertoens M. Janke O. Schmetzer Z. Qin C. Berek T. Blankenstein
January 01, 2004 / Gene Ther Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1/TH2 polarization J. Westermann T. Nguyen-Hoai A. Mollweide G. Richter O. Schmetzer H.J. Kim T. Blankenstein B. Doerken A. Pezzutto
August 01, 2004 / Immunity CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions L. Ohl M. Mohaupt N. Czeloth G. Hintzen Z. Kiafard J. Zwirner T. Blankenstein G. Henning R. Foerster
January 01, 2004 / Int J Cancer CD4+ T cell-mediated HER-2/neu-specific tumor rejection in the absence of B cells J.A. Lindencrona S. Preiss T. Kammertoens T. Schueler M. Piechocki W.Z. Wei B. Seliger T. Blankenstein R. Kiessling
July 01, 2004 / Eur J Immunol Dual T cell receptor T cells with two defined specificities mediate tumor suppression via both receptors M. Gladow W. Uckert T. Blankenstein
December 01, 2014 / Canc Res Efficacy of CAR T-cell therapy in large tumors relies upon stromal targeting by IFNγ A. Textor J.J. Listopad L.L. Wührmann C. Perez A. Kruschinski M. Chmielewski H. Abken T. Blankenstein J. Charo
July 28, 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein